BR112013019798A2 - bakuchiol compositions for treating postinflammatory hyperpigmentation. - Google Patents

bakuchiol compositions for treating postinflammatory hyperpigmentation.

Info

Publication number
BR112013019798A2
BR112013019798A2 BR112013019798A BR112013019798A BR112013019798A2 BR 112013019798 A2 BR112013019798 A2 BR 112013019798A2 BR 112013019798 A BR112013019798 A BR 112013019798A BR 112013019798 A BR112013019798 A BR 112013019798A BR 112013019798 A2 BR112013019798 A2 BR 112013019798A2
Authority
BR
Brazil
Prior art keywords
treating
postinflammatory hyperpigmentation
bakuchiol compositions
bakuchiol
compositions
Prior art date
Application number
BR112013019798A
Other languages
Portuguese (pt)
Inventor
Alfaro Brownell Lidia
Feng Hong Mei
Jia Qi
Original Assignee
Unigen Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Unigen Inc filed Critical Unigen Inc
Priority claimed from PCT/US2012/023686 external-priority patent/WO2012106551A1/en
Publication of BR112013019798A2 publication Critical patent/BR112013019798A2/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/045Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A61K31/05Phenols
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/60Salicylic acid; Derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • A61P17/02Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • A61P17/10Anti-acne agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • A61P17/16Emollients or protectives, e.g. against radiation
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • A61P17/18Antioxidants, e.g. antiradicals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/02Immunomodulators
BR112013019798A 2011-02-02 2012-02-02 bakuchiol compositions for treating postinflammatory hyperpigmentation. BR112013019798A2 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201161438890P 2011-02-02 2011-02-02
PCT/US2011/026594 WO2012105990A1 (en) 2011-02-02 2011-03-01 Bakuchiol compositions for treatment of post inflammatory hyperpigmentation
PCT/US2012/023686 WO2012106551A1 (en) 2011-02-02 2012-02-02 Bakuchiol compositions for treatment of post inflammatory hyperpigmentation

Publications (1)

Publication Number Publication Date
BR112013019798A2 true BR112013019798A2 (en) 2017-07-04

Family

ID=46603028

Family Applications (1)

Application Number Title Priority Date Filing Date
BR112013019798A BR112013019798A2 (en) 2011-02-02 2012-02-02 bakuchiol compositions for treating postinflammatory hyperpigmentation.

Country Status (8)

Country Link
KR (5) KR102156731B1 (en)
CN (2) CN105147533B (en)
AU (1) AU2012212153B9 (en)
BR (1) BR112013019798A2 (en)
CA (4) CA2826262C (en)
HK (1) HK1215792A1 (en)
MX (1) MX350719B (en)
WO (1) WO2012105990A1 (en)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10471035B2 (en) 2014-10-20 2019-11-12 Sunny BioDiscovery Compositions and methods for using esters of meroterpenes and of other resveratrol analogues
CN105675741A (en) * 2015-12-30 2016-06-15 成都九芝堂金鼎药业有限公司 Method for determining content of effective components in hair growing pill
KR20190116858A (en) 2018-04-05 2019-10-15 주식회사 엑소코바이오 A composition comprising an exosome and/or extracellular vesicle derived from stem cell as an active ingredient and its application for preventing, alleviating, reducing or removing postinflammatory hyperpigmentation
CN111544317B (en) * 2020-04-29 2022-01-14 珀莱雅化妆品股份有限公司 Anti-aging composition cationic nano-liposome and preparation method and application thereof
CN114478196B (en) * 2021-01-27 2023-11-10 江苏巴帝恩生物科技有限公司 Method for extracting and purifying bakuchiol from Ulmus pumila root and application of bakuchiol in cosmetics

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2617473B2 (en) 1987-06-30 1997-06-04 キヤノン株式会社 Information input device
KR101802415B1 (en) * 2005-05-09 2017-11-28 유니젠, 인크. Compositions of bakuchiol and methods of making the same
EP2144608B1 (en) * 2007-05-14 2017-01-25 Sytheon Ltd. Sunscreen compositions and methods

Also Published As

Publication number Publication date
AU2012212153B9 (en) 2017-05-11
CA3128715A1 (en) 2012-08-09
WO2012105990A1 (en) 2012-08-09
CN103458882A (en) 2013-12-18
CA3128718A1 (en) 2012-08-09
KR20200108120A (en) 2020-09-16
CA3128711A1 (en) 2012-08-09
MX350719B (en) 2017-09-14
KR102156731B1 (en) 2020-09-16
KR102642352B1 (en) 2024-02-28
KR20230058727A (en) 2023-05-03
CA2826262C (en) 2021-10-26
KR102525516B1 (en) 2023-04-24
AU2012212153B2 (en) 2017-04-06
KR20190025740A (en) 2019-03-11
HK1215792A1 (en) 2016-09-15
AU2012212153A1 (en) 2013-08-29
KR101954118B1 (en) 2019-03-05
KR20140008364A (en) 2014-01-21
CN103458882B (en) 2015-08-05
KR20210145864A (en) 2021-12-02
MX2013008890A (en) 2013-10-17
KR102333655B1 (en) 2021-12-01
CN105147533B (en) 2018-07-31
CN105147533A (en) 2015-12-16
CA2826262A1 (en) 2012-08-09

Similar Documents

Publication Publication Date Title
CO6960110A1 (en) Additive composition for well treatment fluids
BR112013019732A2 (en) compositions and methods for treating cardiovascular disease
BR112013021368A2 (en) implantation, especially for occlusion of bifurcal abeurysms
BR112014012159A2 (en) phytocannabinoid tetrahydrocannabivarin
BR112013030885A2 (en) Stevia composition.
CO6890100A2 (en) Combination treatments for hepatitis c
BR302012000171S1 (en) Beaker setting.
BR112013028128A2 (en) polymer composition for fixtures
DK2741763T3 (en) COMPOSITION FOR CONTROLLED OVARI STIMULATION.
BR112013019327A2 (en) compound and composition.
BR112012004080A2 (en) pharmaceutical compositions for treating ibd
BR112014028622A2 (en) glucokinase activator compositions for treating diabetes
BR112015006512A2 (en) composition for treating damaged biological tissues
BR112014013614A2 (en) antimicrobial composition, method for disinfecting a surface and use of a composition
BR112013028282A2 (en) polymer composition for fixtures
BR112013030897A2 (en) composition.
BR112014012759A2 (en) compound, composition and method for treatment
BR112013019798A2 (en) bakuchiol compositions for treating postinflammatory hyperpigmentation.
BR112013031544A2 (en) topical composition.
BR112013028890A2 (en) compositions and methods for cancer treatment
FI20115862A0 (en) Lipid composition for preventing or treating skin problems
EP2689777A4 (en) Pharmaceutical composition for treating hepatic disease
TWI561912B (en) Photoresist composition
DE102011111940A8 (en) Walk-in, flat-running gate
IT1403537B1 (en) DEODORANT COMPOSITION.

Legal Events

Date Code Title Description
B07D Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]
B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B07E Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette]

Free format text: NOTIFICACAO DE ANUENCIA RELACIONADA COM O ART 229 DA LPI

B06T Formal requirements before examination [chapter 6.20 patent gazette]
B07A Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
B09B Patent application refused [chapter 9.2 patent gazette]
B12B Appeal against refusal [chapter 12.2 patent gazette]